BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3931050)

  • 1. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
    Badalian LO; Temin PA; Grinio ZN; Amanova ZN; Sadovskaia IuE
    Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
    Badalian LO; Temin PA; Amanova ZN; Avakian GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1630-5. PubMed ID: 6441403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Badalian LO; Amanova ZN; Temin PA
    Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diurnal rhythm of catecholamines and DOPA excretion in the urine of obese children].
    Solov'ev AN; Kartelishev AV; Severtseva VV
    Pediatriia; 1977 Sep; (9):24-8. PubMed ID: 563049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
    Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of using Nakom in diseases of the nervous system].
    Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.
    Dalmaz Y; Peyrin L; Mamelle JC; Tuil D; Gilly R; Cier JF
    J Neural Transm; 1979; 46(1):17-34. PubMed ID: 501348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Free catecholamines and DOPA in healthy children 4-17 years of age].
    Gugutishvili TsG
    Pediatriia; 1974 Dec; (12):42-3. PubMed ID: 4444904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
    Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN; Matlina ESh
    Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
    Kharchenko AD; Kniazev IuA; Bukhny AE; Kovalev GP; Kosiakov GA
    Pediatriia; 1969 May; 48(5):51-4. PubMed ID: 4309285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Johnson WW
    Indian Heart J Teach Ser; 1980; (6):258-75. PubMed ID: 7309047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
    Brin IL; Drozdov AZ; Kovaleva IA; Filatova TS; Kogan BM
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):7-12. PubMed ID: 7975996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [State of catecholamine and DOPA excretion in metabolic-alimentary obesity].
    Frolova IA; Beiul EA; Volkova IS; Sirota II
    Vopr Med Khim; 1974 May; 20(3):257-65. PubMed ID: 4836785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrocardiographic study of progressive muscular dystrophy Duchenne's type].
    De los Arcos E; Sánchez Cascos A; De Rábago P
    Rev Esp Cardiol; 1969; 22(2):193-200. PubMed ID: 5801957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.